A Practical Approach to Newborn Screening for Severe Combined Immunodeficiency Using the T Cell Receptor Excision...

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Severe combined immunodeficiency (SCID) is a critical genetic disorder affecting T cell development in infants.
• Newborn screening (NBS) for SCID using the T cell receptor excision circle (TREC) assay is now standard in all US states.
• The TREC assay demonstrates high sensitivity for detecting SCID in newborns.

Purpose of the Study:

• To review the current state of NBS for SCID.
• To highlight ongoing controversies in the management of positive NBS results.
• To address the evolving approach to infants with T cell lymphopenia detected by NBS.

Main Methods:

• Review of current literature and established guidelines for SCID NBS.
• Analysis of existing state-specific protocols for handling screening positives.
• Discussion of diagnostic workup, infection prophylaxis, and treatment timelines.

Main Results:

• NBS for SCID via TREC assay is sensitive but can yield false positives or identify non-SCID T cell lymphopenia.
• Significant variability exists among states in confirmatory testing, diagnostic procedures, and treatment initiation.
• Management strategies for infants with T cell lymphopenia not meeting SCID criteria are still developing.

Conclusions:

• While NBS for SCID is effective, standardized protocols for follow-up care are crucial.
• Further research and consensus are needed to optimize the management of SCID and related conditions identified through NBS.
• Consistent approaches to confirmatory testing, diagnostics, and treatment are essential for improving infant outcomes.